OraSure Technologies

📍 Bethlehem, United States🗓 Founded 1987👥 489 employees💰 Last funded Aug 2019
Medical Equipment Manufacturing🌐 OraSure.com
Website LinkedIn
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1987
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in OraSure Technologies?
OraSure Technologies has 1 investors on record on gritt.io.
When did OraSure Technologies last raise funding?
The most recent investment in OraSure Technologies recorded on gritt.io was in August 2019.
When was OraSure Technologies founded?
OraSure Technologies was founded in 1987.
What industry is OraSure Technologies in?
OraSure Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is OraSure Technologies based?
OraSure Technologies is headquartered in Bethlehem, United States.